Glucagon-like peptide 1 receptor agonists and thyroid cancer: is it the time to be concerned?

Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have changed considerably the management of type 2 diabetes (T2D). However, recently published data from retrospective cohort studies suggest that chronic exposure to GLP-1RAs in T2D may increase the risk of papillary and medullary thyroid cancer....

Descripción completa

Detalles Bibliográficos
Autores principales: Lisco, Giuseppe, De Tullio, Anna, Disoteo, Olga, Piazzolla, Giuseppina, Guastamacchia, Edoardo, Sabbà, Carlo, De Geronimo, Vincenzo, Papini, Enrico, Triggiani, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563602/
https://www.ncbi.nlm.nih.gov/pubmed/37656509
http://dx.doi.org/10.1530/EC-23-0257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563602/
https://www.ncbi.nlm.nih.gov/pubmed/37656509
http://dx.doi.org/10.1530/EC-23-0257

Ejemplares similares